1. Andersen, H.R., Andersson, A.M., Arnold, S.F., Autrup, H., Barfoed, M., Beresford, N.A., Bjerregaard, P., Christiansen, L.B., Gissel, B., Hummel, R., Jorgensen, E.B., Korsgaard, B., Le Guevel, R., Leffers, H., McLachlan, J., Moller, A., Nielsen, J.B., Olea, N., Oles-Karasko, A., Pakdel, F., Pedersen, K.L., Perez, P., Skakkeboek, N.E., Sonnenschein, C., Soto, A.M., Sumpter, J.P., Thorpe, S.M., Grandjean, P., 1999. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. 107(Suppl. 1), 89–108.
2. Issues arising when interpreting results from an in vitro assay for estrogenic activity;Beresford;Toxicology and Applied Pharmacology,2000
3. DG Environment, 2002. Endocrine Disrupting Substances. Doc no. B4-3040/2001/325850/MAR/C2.
4. European Commission, Directive 2003/53/EC of the European Parliament and of the Council of 18 June 2003 amending for the 26th time Council Directive 76/769/EEC relating to restrictions on the marketing and use of certain dangerous substances and preparations.
5. European Union, 1982. Constructing EINECS. Basic Documents, ISBN 92-825-2456-6.